{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:22:21Z","timestamp":1791361341743,"version":"4.3.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.atherosclerosis.2024.117573","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T08:39:15Z","timestamp":1714984755000},"page":"117573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Induction of let-7d-5p miRNA modulates aortic smooth muscle inflammatory signaling and phenotypic switching"],"prefix":"10.1016","volume":"395","author":[{"given":"Tanwi","family":"Vartak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciar\u00e1n","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-5474","authenticated-orcid":false,"given":"Eoin","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.117573_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","article-title":"Atherosclerosis: Successes, Surprises, and future challenges","volume":"118","author":"Libby","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib4","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib5","doi-asserted-by":"crossref","first-page":"24F","DOI":"10.1016\/j.amjcard.2005.06.009","article-title":"Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol","volume":"96","author":"Liao","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib7","doi-asserted-by":"crossref","first-page":"II18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Schonbeck","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib8","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib9","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib10","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective effect of let-7 miRNA family in regulating inflammation in Diabetes-associated atherosclerosis","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2012060550","article-title":"Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1","volume":"24","author":"Brennan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gde.2011.04.003","article-title":"MicroRNAs and developmental timing","volume":"21","author":"Ambros","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acs.molpharmaceut.5b00756","article-title":"Combined delivery of let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the treatment of KRAS Mutant Cancer","volume":"13","author":"Dai","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy268","article-title":"Circulating let-7 levels in Serum Correlate with the Severity of hepatic fibrosis in chronic hepatitis C","volume":"5","author":"Matsuura","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","author":"Pandit","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep42916","article-title":"Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease","volume":"7","author":"Faccini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbi.2020.01.026","article-title":"let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia\/reperfusion stroke model","volume":"87","author":"Bernstein","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003976","article-title":"Oxidized low-density lipoprotein (OxLDL)-Treated Dendritic cells promote activation of T cells in human atherosclerotic plaque and blood, which is Repressed by statins: microRNA let-7c is integral to the effect","volume":"5","author":"Frostegard","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/ijmm.2017.2995","article-title":"MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo","volume":"40","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071522","article-title":"MicroRNA let-7d-3p contributes to cardiac protection via targeting HMGA2","volume":"20","author":"Wong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib23","article-title":"Atherosclerosis-associated endothelial cell apoptosis by miRNA let7-b-mediated downregulation of HAS-2","author":"Zhu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib24","article-title":"Induction of microRNA hsa-let-7d-5p, and repression of HMGA2, contribute protection against lipid accumulation in macrophage 'foam' cells","volume":"1866","author":"Lightbody","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12920-015-0082-4","article-title":"Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina","volume":"8","author":"Li","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.tips.2018.09.005","article-title":"MicroRNAs: novel molecular targets and response Modulators of statin therapy","volume":"39","author":"Mohajeri","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13388","article-title":"Statins: Epidrugs with effects on endothelial health?","volume":"50","author":"Mohammadzadeh","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2011.08.005","article-title":"Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal","volume":"217","author":"Satoh","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib29","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","article-title":"Single-cell Genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib30","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.049922","article-title":"Fate and state of vascular smooth muscle cells in atherosclerosis","volume":"143","author":"Miano","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib31","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1161\/ATVBAHA.121.316600","article-title":"Six Shades of vascular smooth muscle cells Illuminated by KLF4 (Kruppel-Like factor 4)","volume":"41","author":"Yap","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib32","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins Protect against inflammation in Diabetes-associated atherosclerosis","volume":"67","author":"Brennan","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and Reverse Diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix120","article-title":"SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data","volume":"7","author":"Chen","year":"2018","journal-title":"GigaScience"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib36","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576516","article-title":"microRNA-155 is Decreased during atherosclerosis Regression and is increased in Urinary extracellular Vesicles during atherosclerosis progression","volume":"11","author":"Fitzsimons","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2310\/JIM.0b013e3181ff46d7","article-title":"MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages","volume":"58","author":"Huang","year":"2010","journal-title":"J Investig Med"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2019.00463","article-title":"miR-155 in the Resolution of atherosclerosis","volume":"10","author":"Bruen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2012.01.020","article-title":"The magic and mystery of microRNA-27 in atherosclerosis","volume":"222","author":"Chen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.25846","article-title":"MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia","volume":"57","author":"Vickers","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/kjm2.12092","article-title":"MiR-27 alleviates myocardial cell damage induced by hypoxia\/reoxygenation via targeting TGFBR1 and inhibiting NF-kappaB pathway","volume":"35","author":"Zhang","year":"2019","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib43","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1159\/000492354","article-title":"miR-27b Suppresses endothelial cell proliferation and migration by targeting Smad7 in Kawasaki disease","volume":"48","author":"Rong","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178278","article-title":"Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells","volume":"12","author":"Hwang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1113\/JP279528","article-title":"Statin-mediated cholesterol depletion exerts coordinated effects on the alterations in rat vascular smooth muscle cell biomechanics and migration","volume":"598","author":"Sanyour","year":"2020","journal-title":"J Physiol"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib47","first-page":"1","article-title":"NF-kappaB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase","volume":"51","author":"Park","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jcmm.16107","article-title":"MiR155 modulates vascular calcification by regulating Akt-FOXO3a signalling and apoptosis in vascular smooth muscle cells","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib49","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages","volume":"122","author":"Nazari-Jahantigh","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8060182","article-title":"miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 Axis in atherogenesis","author":"Ye","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1681\/ASN.2015040460","article-title":"Endothelial Kruppel-like factor 4 Mediates the protective effect of statins against Ischemic AKI","volume":"27","author":"Yoshida","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096005","article-title":"Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells","volume":"9","author":"Maejima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.117573_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T21:02:19Z","timestamp":1726261339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"alternative-id":["S0021915024001333"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117573","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of let-7d-5p miRNA modulates aortic smooth muscle inflammatory signaling and phenotypic switching","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117573"}}